256
4D Molecular Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
221
FY23:
297
FY24:
435
FY25:
413
(positive)
Change from FY21 to FY25
millions USD
FY21:
97.2
FY22:
41.3
FY23:
43.3
FY24:
125
FY25:
154
Total assets
Change from FY21 to FY25
millions USD
FY21:
353
FY22:
262
FY23:
340
FY24:
560
FY25:
567
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
16.3
FY22:
15.7
FY23:
19.0
FY24:
29.1
FY25:
44.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
18.0
FY22:
14.8
FY23:
13.1
FY24:
20.6
FY25:
17.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
319
FY22:
231
FY23:
308
FY24:
511
FY25:
506
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
353
FY22:
262
FY23:
340
FY24:
560
FY25:
567
All amounts in millions USD